.@thehill: The measure imposes a new limit on price increases in Medicare's prescription drug program, called Part D, forcing drug companies to pay money back if prices rise above inflation. The measure also caps Medicare beneficiaries' out-of-pocket costs.
-
-
Show this thread
-
The
@USCBO said the measure saves taxpayers $85 billion in Medicare over 10 years, and beneficiaries will save $27 billion in out of pocket costs.Show this thread
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.